|
WO2002072576A1
(en)
|
2001-03-09 |
2002-09-19 |
Pfizer Products Inc. |
Benzimidazole anti-inflammatory compounds
|
|
JP4692281B2
(ja)
|
2003-08-05 |
2011-06-01 |
味の素株式会社 |
新規アゾール化合物
|
|
JP4653660B2
(ja)
|
2003-09-04 |
2011-03-16 |
独立行政法人理化学研究所 |
ＴＧＦ−β活性化制御領域の切断面を認識する抗体
|
|
US20070276050A1
(en)
|
2006-02-27 |
2007-11-29 |
Gilead Sciences, Inc. |
Methods for identifying ASK1 inhibitors useful for preventing and/or treating cardiovascular diseases
|
|
AU2009243756B2
(en)
|
2008-05-05 |
2013-06-27 |
Sanofi-Aventis |
Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
|
|
US8455499B2
(en)
|
2008-12-11 |
2013-06-04 |
Amira Pharmaceuticals, Inc. |
Alkyne antagonists of lysophosphatidic acid receptors
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
GB2470833B
(en)
|
2009-06-03 |
2011-06-01 |
Amira Pharmaceuticals Inc |
Polycyclic antagonists of lysophosphatidic acid receptors
|
|
TWI625121B
(zh)
|
2009-07-13 |
2018-06-01 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
|
JP2013501064A
(ja)
|
2009-08-04 |
2013-01-10 |
アミラ ファーマシューティカルス，インコーポレーテッド |
リゾホスファチジン酸受容体アンタゴニストとしての化合物
|
|
JP5708936B2
(ja)
|
2009-09-25 |
2015-04-30 |
アステラス製薬株式会社 |
置換アミド化合物
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
|
WO2011159550A2
(en)
|
2010-06-14 |
2011-12-22 |
Amidra Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonist and uses thereof
|
|
WO2011159632A1
(en)
|
2010-06-15 |
2011-12-22 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
|
|
PH12012500542A1
(en)
|
2010-09-24 |
2012-11-12 |
Astellas Pharma Inc |
Substituted amide compound
|
|
CN107721940A
(zh)
|
2010-12-07 |
2018-02-23 |
阿米拉制药公司 |
多环lpa1拮抗剂及其使用
|
|
WO2012078593A2
(en)
|
2010-12-07 |
2012-06-14 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonists and uses thereof
|
|
US8785442B2
(en)
|
2011-01-30 |
2014-07-22 |
Curegenix, Inc. |
Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
|
|
CN103596947A
(zh)
|
2011-04-05 |
2014-02-19 |
艾米拉医药股份有限公司 |
用于治疗纤维化、疼痛、癌症和呼吸、过敏性、神经系统疾病或心血管疾病的基于3-或5-联苯-4-基异噁唑的化合物
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
EP2744807A4
(en)
|
2011-08-15 |
2015-03-04 |
Intermune Inc |
COMPOUNDS AS LYSOPHOSPHIC ACID RECEPTOR ANTAGONISTS
|
|
MX370976B
(es)
|
2011-11-11 |
2020-01-10 |
Gilead Apollo Llc |
Inhibidores de acetil coa carboxilasa (acc) y usos de los mismos.
|
|
US20140329871A1
(en)
|
2011-12-04 |
2014-11-06 |
Angion Biomedica Corp. |
Small molecule anti-fibrotic compounds and uses thereof
|
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
|
WO2013134365A1
(en)
|
2012-03-08 |
2013-09-12 |
Ludwig Institute For Cancer Research Ltd |
TGF-β1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
|
|
SG11201407220YA
(en)
|
2012-06-20 |
2014-12-30 |
Hoffmann La Roche |
N-alkyltriazole compounds as lpar antagonists
|
|
HK1206339A1
(en)
|
2012-06-20 |
2016-01-08 |
霍夫曼-拉罗奇有限公司 |
N-aryltriazole compounds as lpar antagonists
|
|
CN104411690A
(zh)
*
|
2012-06-20 |
2015-03-11 |
霍夫曼-拉罗奇有限公司 |
作为lpar拮抗剂的取代的吡唑化合物
|
|
BR112015003998A2
(pt)
|
2012-09-05 |
2017-07-04 |
Hoffmann La Roche |
compostos de cianopirazol lpar-substituídos
|
|
US9567310B2
(en)
|
2012-11-09 |
2017-02-14 |
Inserm (Institut National De La Sante Et De La Recharche Medicale) |
Benzene sulfonamide thiazole compounds
|
|
EP2940013B1
(en)
|
2012-12-28 |
2018-02-21 |
Ube Industries, Ltd. |
Halogen-substituted heterocyclic compound
|
|
TW201437200A
(zh)
*
|
2013-01-15 |
2014-10-01 |
Intermune Inc |
溶血磷脂酸受體拮抗劑
|
|
SG11201507459YA
(en)
|
2013-03-15 |
2015-10-29 |
Epigen Biosciences Inc |
Heterocyclic compounds useful in the treatment of disease
|
|
AU2014262638A1
(en)
|
2013-05-10 |
2015-11-26 |
Gilead Apollo, Llc |
ACC inhibitors and uses thereof
|
|
AU2014298373B2
(en)
|
2013-08-01 |
2019-12-05 |
Ludwig Institute For Cancer Research Ltd |
Anti-GARP protein and uses thereof
|
|
GB201314926D0
(en)
|
2013-08-20 |
2013-10-02 |
Takeda Pharmaceutical |
Novel Compounds
|
|
EP3062827A1
(en)
|
2013-10-31 |
2016-09-07 |
Bristol-Myers Squibb Company |
Radioligands for imaging the lpa-1 receptor
|
|
WO2015199234A1
(ja)
|
2014-06-27 |
2015-12-30 |
宇部興産株式会社 |
ハロゲン置換へテロ環化合物の塩
|
|
SG11201705721WA
(en)
|
2015-01-14 |
2017-08-30 |
Brigham & Womens Hospital Inc |
Treatment of cancer with anti-lap monoclonal antibodies
|
|
JPWO2017086430A1
(ja)
|
2015-11-20 |
2018-09-06 |
宇部興産株式会社 |
Ｎａｓｈの治療又は予防のための医薬組成物
|
|
CA3155220C
(en)
|
2016-03-02 |
2024-01-16 |
Gilead Apollo, Llc |
Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
|
|
AR108185A1
(es)
|
2016-04-06 |
2018-07-25 |
Abbvie Inc |
Amidas terciarias y método para su uso
|
|
AR108838A1
(es)
|
2016-06-21 |
2018-10-03 |
Bristol Myers Squibb Co |
Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
|
|
CN110382530A
(zh)
|
2017-01-06 |
2019-10-25 |
供石公司 |
亚型特异性、背景许可性TGFβ1抑制剂及其用途
|
|
WO2019041340A1
(en)
|
2017-09-04 |
2019-03-07 |
Eli Lilly And Company |
LYSOPHOSPHATIDE ACID RECEPTOR 1 RECEPTOR INHIBITORS (LPAR1)
|
|
WO2019113123A1
(en)
|
2017-12-04 |
2019-06-13 |
Precithera, Inc. |
TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
|
|
JP7348899B2
(ja)
|
2017-12-08 |
2023-09-21 |
マレンゴ・セラピューティクス，インコーポレーテッド |
多重特異性分子及びその使用
|
|
CN111712492B
(zh)
|
2017-12-19 |
2024-05-31 |
百时美施贵宝公司 |
作为lpa拮抗剂的环己基酸三唑唑类
|
|
ES2962367T3
(es)
*
|
2017-12-19 |
2024-03-18 |
Bristol Myers Squibb Co |
Acidos carbamoil ciclohexílicos N-enlazados a pirazol como antagonistas de receptores del ácido lisofosfatídico (LPA)
|
|
US11447475B2
(en)
|
2017-12-19 |
2022-09-20 |
Bristol-Myers Squibb Company |
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
|
|
CA3085561A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid triazole azines as lpa antagonists
|
|
JP7369125B2
(ja)
|
2017-12-19 |
2023-10-25 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのイソキサゾールｏ－架橋カルバモイルシクロヘキシル酸
|
|
JP7212047B2
(ja)
|
2017-12-19 |
2023-01-24 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール
|
|
PE20210655A1
(es)
|
2017-12-19 |
2021-03-31 |
Bristol Myers Squibb Co |
Carbamoil ciclohexil acidos ligados a n de triazol como antagonistas de lpa
|
|
KR102725744B1
(ko)
|
2017-12-19 |
2024-11-01 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헥실 산 피라졸 아진
|
|
WO2019126087A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azoles as lpa antagonists
|
|
US11319309B2
(en)
|
2017-12-19 |
2022-05-03 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azines as LPA antagonists
|
|
JP7202383B2
(ja)
|
2017-12-19 |
2023-01-11 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのピラゾールｏ－架橋カルバモイルシクロヘキシル酸
|
|
KR102800284B1
(ko)
|
2018-09-18 |
2025-04-23 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헵틸 산
|
|
ES2946657T3
(es)
*
|
2018-09-18 |
2023-07-24 |
Bristol Myers Squibb Co |
Acidos ciclopentílicos como antagonistas de LPA
|
|
JP7412424B2
(ja)
|
2018-09-18 |
2024-01-12 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのオキサビシクロ酸
|
|
AU2019362770B2
(en)
|
2018-10-15 |
2025-01-23 |
Bristol-Myers Squibb Company |
Radioligands for imaging the LPA1 receptor
|
|
US12466804B2
(en)
|
2019-06-18 |
2025-11-11 |
Bristol-Myers Squibb Company |
Cyclobutyl carboxylic acids as LPA antagonists
|
|
EP3986552B1
(en)
|
2019-06-18 |
2024-09-18 |
Bristol-Myers Squibb Company |
Isoxazole carboxylic acids as lpa antagonists
|
|
KR20220024548A
(ko)
|
2019-06-18 |
2022-03-03 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 트리아졸 카르복실산
|
|
IL289951B2
(en)
|
2019-07-30 |
2025-10-01 |
Taisho Pharmaceutical Co Ltd |
Urea compound as an LPA1 receptor antagonist
|
|
CN114728168B
(zh)
|
2019-11-15 |
2024-04-09 |
吉利德科学公司 |
三唑氨基甲酸酯吡啶基磺酰胺作为lpa受体拮抗剂及其用途
|
|
WO2021110805A1
(en)
|
2019-12-04 |
2021-06-10 |
Idorsia Pharmaceuticals Ltd |
Combination of an azetidine lpa1 receptor antagonist with pirfenidone and/or nintedanib for use in the treatment of fibrotic diseases
|
|
TWI843503B
(zh)
|
2020-06-03 |
2024-05-21 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
US11702407B2
(en)
|
2020-06-03 |
2023-07-18 |
Gilead Sciences, Inc. |
LPA receptor antagonists and uses thereof
|
|
ES2991765T3
(es)
|
2020-07-16 |
2024-12-04 |
Chiesi Farm Spa |
Derivados del ácido amido ciclohexano como inhibidores del receptor de LPA
|
|
IL300525A
(en)
|
2020-08-11 |
2023-04-01 |
Viva Star Biosciences Ltd |
Triazole-pyridinyl-substituted azacyclohexyl acetic acid compounds as LPA receptor antagonists
|
|
CN114456147B
(zh)
|
2020-11-10 |
2025-07-15 |
武汉人福创新药物研发中心有限公司 |
氧取代氨基碳酸酯噻吩类化合物
|
|
WO2022100623A1
(zh)
|
2020-11-10 |
2022-05-19 |
武汉人福创新药物研发中心有限公司 |
氮取代杂环噻吩类化合物及其用途
|
|
WO2022100625A1
(zh)
|
2020-11-10 |
2022-05-19 |
武汉人福创新药物研发中心有限公司 |
氮取代氨基碳酸酯噻吩类化合物及其用途
|
|
WO2022174882A1
(en)
|
2021-02-16 |
2022-08-25 |
Chiesi Farmaceutici S.P.A. |
5-membered heterocyclyl carbamate derivatives as dual lpa receptor 1 and lpa receptor 2 inhibitors
|
|
WO2022174883A1
(en)
|
2021-02-16 |
2022-08-25 |
Chiesi Farmaceutici S.P.A. |
5-membered heterocyclyl derivatives as dual lpa receptor 1 and lpa receptor 2 inhibitors
|
|
KR20240007233A
(ko)
|
2021-05-13 |
2024-01-16 |
길리애드 사이언시즈, 인코포레이티드 |
Lpa 수용체 길항제 및 이의 용도
|
|
US11939318B2
(en)
|
2021-12-08 |
2024-03-26 |
Gilead Sciences, Inc. |
LPA receptor antagonists and uses thereof
|